selected scholarly activity
-
books
-
conferences
- COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN PSORIATIC ARTHRITIS: A CANADIAN PERSPECTIVE. Value in Health. A145-A145. 2017
- SAT0348 The Economic Value of Tofacitinib 5 Mg Bid in the Treatment of Moderate to Severe Rheumatoid Arthritis: A Canadian Analysis. Annals of the Rheumatic Diseases. 785.1-785. 2015
- The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian Analysis. Value in Health. A160-A161. 2015
- COST UTILITY ANALYSIS OF BOTOX VS. ANTICHOLINERGIC MEDICATION FOR URINARY INCONTINENCE, DUE TO NEUROGENIC DETRUSOR OVERACTIVITY ASSOCIATED WITH SPINAL CORD INJURY OR MULTIPLE SCLEROSIS. Journal of Epidemiology and Community Health. A5.1-A5. 2015
- Prevalence And Incidence Of Idiopathic Pulmonary Fibrosis In Canada. American Journal of Respiratory and Critical Care Medicine. 2015
- A systematic review of methodological frameworks for evaluation of ethical considerations in health technology assessment. Value in Health. A200-A200. 2014
- Burden of illness of diabetic foot ulcers in Canada. Value in Health. A246-A246. 2014
- Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting. Value in Health. A90-A90. 2014
- Cost-Utility Analysis of Practice Deviations From Guidelines in HER2-Targeted Testing and Treatment for Breast Cancer. Value in Health. A91-A91. 2014
- Evaluation Of A Chronic Disease Management System For The Treatment And Management Of Diabetes In Primary Health Care Practices In Ontario. Value in Health. A144-A144. 2014
- Prevalence And Incidence Of Interstitial Pulmonary Diseases With Fibrosis. Value in Health. A171-A171. 2014
- Screening For Type 2 Diabetes: A Methodological Review And Cost Analysis. Value in Health. A126-A126. 2014
- Survival crossover adjustment and cost effectiveness analysis: An empirical and methodological review with application. Value in Health. A202-A202. 2014
- Abstract P6-07-02: Pharmacoeconomic evaluation of denosumab for the treatment of bone metastases in patients with advanced breast cancer in Canada. Cancer Research. 2013
- Prehospital Evaluation and Economic Analysis of DIfferent Coronary Syndrome Treatment Strategies (PREDICT)-A Prospective Cohort Study. Circulation. 2013
- Economic Evaluation of Ticagrelor Versus Clopidogrel in Canadian Patients With Acute Coronary Syndromes Based on the Platelet Inhibition and Patient Outcomes (Plato) Trial. Canadian Journal of Cardiology. S299-S299. 2013
- CAN INDIVIDUAL HEALTH TECHNOLOGIES IMPROVE OVERALL CHRONIC DISEASE MANAGEMENT?. Value in Health. A264-A264. 2013
- Cost-effectiveness of ticagrelor versus generic clopidogrel in patients with acute coronary syndromes in Canada. Value in Health. A285-A285. 2013
- Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies. Value in Health. A264-A264. 2013
- Harmonization Of Health Technology Assessement And Regulatory Processes And Evidentiary Requirements For Drugs And Devices: Opportunities And Challenges. Value in Health. A249-A249. 2013
- How can we use discrete event simulation to improve access to health care: an assessment of increasing access to care for children with medically refractory epilepsy. Value in Health. A108-A109. 2013
- Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems. Value in Health. A288-A288. 2013
- Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplant in Comparison to Non-Bridged Cardiac Recipients. The Journal of Heart and Lung Transplantation. S145-S145. 2013
- CHARACTERISTICS OF THE ABORIGINAL PEOPLE WITH DIABETES IN THE SOUTH-WESTERN OF ONTARIO, CANADA. Value in Health. A495-A496. 2012
- PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada. Value in Health. A499-A499. 2012
- PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada. Value in Health. A507-A507. 2012
- PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis. Value in Health. A325-A325. 2012
- COST-EFFECTIVENESS OF VENTRICULAR ASSIST DEVICE THERAPY AS A BRIDGE TO TRANSPLANT IN COMPARISON TO NON-BRIDGED CARDIAC RECIPIENTS. Canadian Journal of Cardiology. S175-S176. 2012
- PIN30 Economic Evaluation of a Cluster Randomized Controlled Trial of an Influenza Immunization Program Directed at Healthy Children. Value in Health. A242-A242. 2012
- PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb: Systematic Review and Meta-Analysis. Value in Health. A63-A63. 2012
- PRM28 Physicians as Pseudo-Agents in a Hospital Emergency Department Discrete Event Simulation. Value in Health. A163-A163. 2012
- COST-CONSEQUENCE ANALYSIS OF CLONIDINE FOR THE PREVENTION OF PERIOPERATIVE CARDIOVASCULAR EVENTS IN NONCARDIAC SURGERY PATIENTS. Anesthesia and Analgesia. 2012
- PCN175 Reimbursement of Anticancer Drugs in Canada: What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?. Value in Health. A466-A466. 2011
- PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada. Value in Health. A373-A373. 2011
- PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter. Value in Health. A250-A250. 2011
- PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies. Value in Health. A260-A260. 2011
- PMS22 The Burden of Illness of Osteoporosis in Canada. Value in Health. A306-A306. 2011
- PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS. Value in Health. A119-A120. 2011
- PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS. Value in Health. A83-A83. 2011
- PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Value in Health. A75-A75. 2011
- PMS21 THE ACUTE CARE COSTS OF OSTEOPOROSIS-RELATED FRACTURES IN CANADA. Value in Health. A306-A306. 2010
- Improving cardiovascular health at the population level: a 39 community cluster-randomized trial of the Cardiovascular Health Awareness Program (C-CHAP). Stroke. E474-E474. 2010
- IMPROVING CARDIOVASCULAR HEALTH AT THE POPULATION LEVEL: A 39 COMMUNITY CLUSTER-RANDOMISED TRIAL OF THE CARDIOVASCULAR HEALTH AWARENESS PROGRAM (CHAP): PS.3.03. Journal of Hypertension. e602-e602. 2010
- HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. A133-A133. 2010
- PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHN'S DISEASE. Value in Health. A73-A73. 2010
- PRS7 TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Value in Health. A197-A197. 2010
- PSY30 COST-EFFECTIVENESS OF BARIATRIC SURGICAL PROCEDURES VERSUS NO TREATMENT FOR MORBID OBESITY. Value in Health. A211-A211. 2010
- UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO. Value in Health. A133-A134. 2010
- DB1 USING POPULATION-BASED ESTIMATES FOR DISEASE MODELING: POTENTIAL BIAS COMPARED TO USING DISEASE-SPECIFIC DEATH AND COMPLICATION RISK ESTIMATES. Value in Health. A234-A234. 2009
- MO3 R THERE ANY DIFFERENCES BETWEEN EXCEL AND R? COMPARISON OF ICER ESTIMATES AND CEACS OBTAINED FROM A MODEL IMPLEMENTED IN MICROSOFT EXCEL AND R. Value in Health. A226-A227. 2009
- PDB21 WHO ARE THEY FOOLING?: COST OF DISEASE OR COMPLICATIONS CAN SIGNIFICANTLY BIAS ESTIMATES UNLESS CONTROL (NON-DISEASED) COSTS ARE NOT ALSO ACCOUNTED FOR IN THE ANALYSIS. Value in Health. A405-A405. 2009
- PG14 SYSTEMATIC REVIEW: THE CLINICAL EFFECTIVENESS OF ANTI-TNFALPHA DRUGS IN ADULTS WITH REFRACTORY CROHN'S DISEASE. Value in Health. A346-A346. 2009
- PHP80 CLINICAL EFFECTIVENESS OF PORTABLE ULTRASOUND IN SMALL EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW. Value in Health. A252-A252. 2009
- PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP. Value in Health. A374-A374. 2009
- PSY18 THE BURDEN OF OBESITY IN ONTARIO. Value in Health. A378-A378. 2009
- PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA. Value in Health. A380-A381. 2009
- PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI-TNF-ALPHA; DRUGS FOR REFRACTORY ULCERATIVE COLITIS. Value in Health. A58-A58. 2009
- PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO. Value in Health. A131-A131. 2009
- QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA. Value in Health. A17-A17. 2009
- CASE2 DOTECHNOLOGY EVALUATIONS BASED ON EVIDENCE FROM CONDITIONAL FUNDING LEAD TO AN INCREASE IN POLICY FORMATION?: FINDINGS FROM, AND IMPLICATIONS OF, ONTARIO'S EVIDENCE-BASED HTA PROCESS. Value in Health. A349-A349. 2008
- Cost of Improvement of Angina-Related Health Status by Health Care System: A Secondary Analysis from the COURAGE Trial. Circulation. S1161-S1161. 2008
- Evaluation of pharmacoepidemiology trials: Rigour methodologica versus rigor mortis. Pharmacoepidemiology and Drug Safety. S81-S81. 2008
- CASE 2 DRUG ELUTING STENTS—AN EXAMPLE OFTHETRANSITION FROM EVIDENCETO POLICYTHROUGHTHE ONTARIO COMPREHENSIVE APPROACHTOTHE DIFFUSION OF HEALTHTECHNOLOGIES. Value in Health. A1-A2. 2008
- PGI7 COST EFFECTIVENESS ANALYSIS OF HELICOBACTER PYLORI SCREENING IN PREVENTION OF GASTRIC CANCER IN CHINESE. Value in Health. A85-A86. 2008
- PHP74 THE CADTH GUIDELINES FORTHE ECONOMIC EVALUATION OF HEALTH TECHNOLOGIES: DO CURRENT CANADIAN ECONOMIC EVALUATIONS PASS THE TEST?. Value in Health. A51-A51. 2008
- PMC15 DETERMINING THE MECHANISM OF MISSING DATA IN INCOMPLETE DATASETS. Value in Health. A173-A174. 2008
- PMS34 ATWO-YEAR EVALUATION OF HEALTH OUTCOMES IN OSTEOARTHRITIS PATIENTS AFTERTOTAL KNEE REPLACEMENT. Value in Health. A265-A265. 2008
- Cost effectiveness of adding PCI to optimal medical therapy in patients with stable coronary artery disease: Economic outcomes from the COURAGE trial. Circulation. 794-794. 2007
- Baseline cardiovascular risk profile of 15,889 seniors participating in C-chap trial. Canadian Journal of Cardiology. 104C-104C. 2007
- Quality of life analysis of the Canadian courage patients. Canadian Journal of Cardiology. 293C-293C. 2007
- Quality-of-life and economic outcomes in the Clinical Outcomes Utilizing Percutaneous coronary Revascularization and Aggressive Guideline-driven Drug Evaluation (COURAGE) trial. Circulation. E551-E551. 2007
- PCV77 DISCRETE-EVENT-SIMULATION AN APPROACH THAT CHALLENGES TRADITIONAL MODELING METHODS? AN ILLUSTRATION USING DRUG-ELUTING STENTS. Value in Health. A361-A361. 2006
- The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women.. Journal of Bone and Mineral Research. S279-S279. 2006
- CE4 COST EFFECTIVENESS OF DRUG ELUTING STENTS (DES) COMPARED TO BARE METAL STENTS (BMS) USING “REAL WORLD” DATA. Value in Health. A8-A8. 2006
- PDB10 MODELLING LIFETIME HEATLH CARE COSTS AND CONSEQUENCES OF A NURSE-LED MULTIFACETED INTERVENTION TO IMPROVE THE MANAGEMENT OF PATIENTS WITH DIABETES: RESULTS FROM A COMPUTERIZED SIMULATION MODEL. Value in Health. A33-A34. 2006
- PDB19 IMPROVING THE MEASUREMENT OF THE COST OF DIABETES-RELATED COMPLICATIONS: RESULTS FROM A LARGE PROSPECTIVE COHORT STUDY. Value in Health. A36-A36. 2006
- PMC1 TRANSFERABILITY OF ECONOMIC EVALUATIONS: CAN RESULTS FROM ONE GEOGRAPHIC AREA BE USED TO HELP INFORM HEALTH CARE DECISION MAKING IN ANOTHER?. Value in Health. A56-A56. 2006
- PSU1 COST-UTILTY OF ELECTIVE ENDOVASCULAR REPAIR (EVAR) COMPARED TO OPEN SURGICAL REPAIR (OSR) OF ABDOMINAL AORTIC ANEURYSMS (AAA). Value in Health. A173-A173. 2006
- PAR16 POTENTIAL PROBLEMS IN USING RCT DATA TO ESTIMATE COST-EFFECTIVENESS: RESULTS FROM AN ANALYSIS OF ETANERCEPT USE IN RHEUMATOID ARTHRITIS. Value in Health. A28-A29. 2005
- A RANDOMIZED TRIAL OF STRATEGIES FOR ASSESSING ELIGIBILITY FOR LONG-TERM DOMICILIARY OXYGEN THERAPY. Chest. 254S-254S. 2005
- PCV26 THE COST-EFFECTIVENESS OF EXTENDED ANTITHROMBOTIC PROPHYLAXIS FOLLOWING TOTAL HIP ARTHROPLASTY. Value in Health. 693-693. 2004
- Photodynamic therapy (PDT) for Barrett's esophagus with high-grade dysplasia (BE+HGD): Cost-effectiveness model with probabilistic sensitivity analysis. Gastrointestinal Endoscopy. AB137-AB137. 2004
- Trickery, deception and economic evaluations: Is there more harm than good?. Osteoporosis International. S105-S105. 2004
- The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.. Journal of Bone and Mineral Research. S384-S384. 2003
- A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 17-22. 2003
- Probabilistic cost-effectiveness analyses of long term management therapies for postmenopausal osteoporosis: Cautions and concerns of results obtained from traditional deterministic sensitivity analyses. Osteoporosis International. S16-S17. 2003
- The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women. Osteoporosis International. S84-S85. 2003
- Costs of epoetin alfa (Eprex (TM)) administration to hemodialysis (HD) patients (pts): A Canadian time and motion study. Journal of the American Society of Nephrology. 221A-221A. 2002
- The effect of clinical risk stratification on the cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study. Circulation. 345-345. 2001
- The cost-effectiveness of calcium and vitamin D or hormone replacement therapy versus no intervention in the prevention of hip fractures in Canadian postmenopausal women.. Journal of Bone and Mineral Research. S534-S534. 2001
- Re-fracture one year following hip fracture in Canada.. Journal of Bone and Mineral Research. S294-S294. 2000
- Cost-effectiveness of the implantable cardioverter defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS). Journal of the American College of Cardiology. 152A-153A. 2000
- Economic evaluation of donepezil for treatment of Alzheimer's disease in Canada. Medical decision making. 482-482. 1998
- Systematic implementation of an advance directive program in nursing homes.. Journal of The American Geriatrics Society. S29-S29. 1998
- Economic evaluation of donepezil (D) for Alzheimer's disease in Canada.. Clinical Pharmacology and Therapeutics. 196-196. 1998
- Where do Canadian hip fracture patients go one year post discharge from acute care hospitals, and what is the cost of their follow-up care?. Journal of Bone and Mineral Research. F560-F560. 1997
- How would Canadian physicians manage dyspepsia if an H-pylori (Hp) test were readily available.. Gastroenterology. A10-A10. 1996
- Economic evaluation of Helicobacter pylori eradication in the management of duodenal ulcer. HELICOBACTER PYLORI. 384-397. 1996
- COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES FOR THE LONG-TERM MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD). Gastroenterology. A27-A27. 1995
- COST-EFFECTIVENESS OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) ERADICATION IN THE LONG-TERM MANAGEMENT OF DUODENAL-ULCER. Gastroenterology. A27-A27. 1995
- Health care directives in the elderly and health care utilization. Contemporary Clinical Trials. 432-432. 1992
- COST-EFFECTIVENESS ANALYSIS (CEA) OF EXTRACRANIAL-INTRACRANIAL ARTERIAL BYPASS (EC/IC BYPASS) SURGERY. Clinical Research. A352-A352. 1987
-
journal articles
- A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada. PharmacoEconomics - Open. 7:199-216. 2023
- Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada. Archives of Osteoporosis. 17:71. 2022
- Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018. CJC OPEN. 4:206-213. 2022
- Evidence-Based Decision Making 3: Health Technology Assessment. Methods in molecular biology (Clifton, N.J.). 2249:429-454. 2021
- A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute gastroenteritis. Nature Communications. 11:2533. 2020
- A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma. Ophthalmology Glaucoma. 3:103-113. 2020
- The value and consequences of using public health technology assessments for private payer decision-making in Canada: one size does not fit all. Journal of Medical Economics. 22:478-487. 2019
- Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. Journal of Medical Economics. 22:390-401. 2019
- Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective. Journal of Medical Economics. 22:45-52. 2019
- Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung and Circulation. 27:666-682. 2018
- Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network. Influenza and other Respiratory Viruses. 12:232-240. 2018
- Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective. Journal of Medical Economics. 21:163-173. 2018
- DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care. 34:290-299. 2018
- Relationship between hyperbaric oxygen therapy and quality of life in participants with chronic diabetic foot ulcers: data from a randomized controlled trial. Acta Diabetologica. 54:823-831. 2017
- Correction: Summary of Glaucoma Diagnostic Testing Accuracy: An Evidence-Based Meta-Analysis. Journal of Clinical Medicine Research. 9:231-231. 2017
- BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles. PharmacoEconomics (Auckland). 34:1051-1065. 2016
- Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report. Value in Health. 19:704-719. 2016
- Response to Comments on Fedorko et al. Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Care 2016;39:392–399. Diabetes Reviews. 39:e136-e137. 2016
- Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes. Journal of Medical Economics. 19:630-644. 2016
- Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada. Journal of Medical Economics. 19:277-291. 2016
- Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial. Diabetes Reviews. 39:392-399. 2016
- Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada. Journal of Medical Economics. 19:191-202. 2016
- Using Digital Health Technology to Prevent and Treat Diabetes. Diabetes Technology and Therapeutics. 18:S56-S68. 2016
- Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension. Journal of the American Society of Hypertension. 10:55-69.e1. 2016
- Cost effectiveness of a systematic guidelines-based approach to the prevention and management of vascular disease in a primary care setting. International Journal of Cardiology. 203:893-899. 2016
- Management of Hospital Formularies in Ontario: Challenges within a Local Health Integration Network. Hospital Pharmacist. 69:187-193. 2016
- Summary of Glaucoma Diagnostic Testing Accuracy: An Evidence-Based Meta-Analysis. Journal of Clinical Medicine Research. 8:641-649. 2016
- Economic burden of illness associated with diabetic foot ulcers in Canada. BMC Health Services Research. 15:13. 2015
- Reducing the confusion and controversies around pragmatic trials: using the Cardiovascular Health Awareness Program (CHAP) trial as an illustrative example. Trials. 16:387. 2015
- Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations. BMC Research Notes. 8:244. 2015
- Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments. Annals of Emergency Medicine. 66:455-463.e4. 2015
- Zrx Mcdm: A Fully Flexible Tool to Support The Local Adaptation of Multiple-Criteria Decision Criteria In Health Care. Value in Health. 18:A703-A703. 2015
- Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies. Expert Review of Pharmacoeconomics and Outcomes Research. 15:451-463. 2015
- A Literature Review of Economic Evaluations for a Neglected Tropical Disease: Human African Trypanosomiasis (“Sleeping Sickness”). PLoS Neglected Tropical Diseases. 9:e0003397-e0003397. 2015
- Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion. Expert Review of Pharmacoeconomics and Outcomes Research. 15:13-19. 2015
- Utility values for pre-menopausal women suffering from symptomatic uterine fibroids. Expert Review of Pharmacoeconomics and Outcomes Research. 15:181-189. 2015
- BARRIERS AND FACILITATORS INFLUENCING ETHICAL EVALUATION IN HEALTH TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care. 31:113-123. 2015
- Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Economic Analysis.. Ontario Health Technology Assessment Series. 15:1-32. 2015
- Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.. Ontario Health Technology Assessment Series. 15:1-43. 2015
- Evidence-Based Decision-Making 3: Health Technology Assessment. Methods in molecular biology (Clifton, N.J.). 1281:417-441. 2015
- Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.. Journal of Population Therapeutics and Clinical Pharmacology. 22:e78-e89. 2015
- Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management. ClinicoEconomics and Outcomes Research. 7:213-213. 2015
- Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey.. Ontario Health Technology Assessment Series. 15:1-67. 2015
- A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials. 15:268. 2014
- Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial. Trials. 15:170. 2014
- Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis. Systematic Reviews. 3:143. 2014
- ECONOMIC EVALUATION OF AN INFLUENZA IMMUNIZATION STRATEGY OF HEALTHY CHILDREN. International Journal of Technology Assessment in Health Care. 30:394-399. 2014
- Systematic Review on the Patient-Reported Outcomes of Tissue-Expander/Implant vs Autologous Abdominal Tissue Breast Reconstruction in Postmastectomy Breast Cancer Patients. Journal of the American College of Surgeons. 218:1038-1048. 2014
- Methodological guidance documents for evaluation of ethical considerations in health technology assessment: a systematic review. Expert Review of Pharmacoeconomics and Outcomes Research. 14:203-220. 2014
- Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study. Hospital Practice. 42:38-45. 2014
- A systematic review of the reporting of sample size calculations and corresponding data components in observational functional magnetic resonance imaging studies. NeuroImage. 86:172-181. 2014
- How to use multi-criteria decision analysis methods for reimbursement decision-making in healthcare: a step-by-step guide. Expert Review of Pharmacoeconomics and Outcomes Research. 14:81-99. 2014
- Safety of Tissue Expander/Implant versus Autologous Abdominal Tissue Breast Reconstruction in Postmastectomy Breast Cancer Patients. Plastic and Reconstructive Surgery. 133:234-249. 2014
- Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada. ClinicoEconomics and Outcomes Research. 6:49-49. 2014
- Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.. Ontario Health Technology Assessment Series. 14:1-37. 2014
- Point-of-Care Hemoglobin A1c Testing: A Budget Impact Analysis.. Ontario Health Technology Assessment Series. 14:1-23. 2014
- The Reporting of Observational Clinical Functional Magnetic Resonance Imaging Studies: A Systematic Review. PLoS ONE. 9:e94412-e94412. 2014
- Access to surgery for paediatric patients with medically refractory epilepsy: A systems analysis. Journal of Epilepsy. 107:286-296. 2013
- Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?. Best Practice and Research in Clinical Gastroenterology. 27:831-844. 2013
- Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation. BMC Medical Informatics and Decision Making. 13:59. 2013
- Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis. Annals of Surgical Oncology. 20:3675-3684. 2013
- Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario. Expert Review of Pharmacoeconomics and Outcomes Research. 13:675-690. 2013
- Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences. Expert Review of Pharmacoeconomics and Outcomes Research. 13:497-511. 2013
- Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. Journal of Thoracic and Cardiovascular Surgery. 146:52-60.e3. 2013
- HYPERBARIC OXYGEN THERAPY FOR DIABETIC ULCERS: SYSTEMATIC REVIEW AND META-ANALYSIS. International Journal of Technology Assessment in Health Care. 29:269-281. 2013
- Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplantation Compared With Nonbridged Cardiac Recipients. Circulation. 127:2424-2435. 2013
- Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates.. Canadian Family Physician. 59:e282-e289. 2013
- The Impact of Using Informative Priors in a Bayesian Cost-Effectiveness Analysis. Medical decision making. 33:437-450. 2013
- Multi-criteria decision analysis (MCDA) in health care: A bibliometric analysis. Operations Research for Health Care. 2:20-24. 2013
- Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporosis International. 24:581-593. 2013
- The Burden of Atrial Fibrillation on the Hospital Sector in Canada. Canadian Journal of Cardiology. 29:229-235. 2013
- A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Journal of the Canadian Urological Association. 7:335-335. 2013
- Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation. International Journal of Vascular Medicine. 2013:1-11. 2013
- Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis.. Ontario Health Technology Assessment Series. 13:1-28. 2013
- Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program. Value in Health. 16:39-45. 2013
- Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework.. Ontario Health Technology Assessment Series. 13:1-78. 2013
- Photoselective vaporization for the treatment of benign prostatic hyperplasia.. Ontario Health Technology Assessment Series. 13:1-34. 2013
- Surrogate outcomes: experiences at the Common Drug Review. Cost Effectiveness and Resource Allocation. 11:31-31. 2013
- The excess burden of rheumatoid arthritis in Ontario, Canada.. Clinical and Experimental Rheumatology. 31:18-24. 2013
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update.. Ontario Health Technology Assessment Series. 13:1-40. 2013
- Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis.. Ontario Health Technology Assessment Series. 13:1-24. 2013
- Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. Journal of Interventional Cardiac Electrophysiology. 35:259-275. 2012
- Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada. Journal of Medical Economics. 15:3-14. 2012
- Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review. Genetic Testing and Molecular Biomarkers. 16:1322-1335. 2012
- The burden of illness of osteoporosis in Canada. Osteoporosis International. 23:2591-2600. 2012
- Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada. Value in Health. 15:894-906. 2012
- The burden of illness of osteoporosis in Canadian men. Journal of Bone and Mineral Research. 27:1830-1838. 2012
- Value of information methods for planning and analyzing clinical studies optimize decision making and research planning. Journal of Clinical Epidemiology. 65:870-876. 2012
- Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records. Journal of the American Medical Informatics Association : JAMIA. 19:341-345. 2012
- The economics of health information technology in medication management: a systematic review of economic evaluations. Journal of the American Medical Informatics Association : JAMIA. 19:423-438. 2012
- MATHEMATICAL MODELING: THE CASE OF EMERGENCY DEPARTMENT WAITING TIMES. International Journal of Technology Assessment in Health Care. 28:93-109. 2012
- Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study. Hospital Practice. 40:131-137. 2012
- The excess burden of osteoarthritis in the province of Ontario, Canada. Arthritis and Rheumatism. 64:1153-1161. 2012
- The drug safety and effectiveness cross-disciplinary training (DSECT) program. Journal of Population Therapeutics and Clinical Pharmacology. 19:66-72. 2012
- Common Drug Review Recommendations. PharmacoEconomics (Auckland). 30:229-246. 2012
- Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporosis International. 23:921-927. 2012
- Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease. Journal of Crohn's and Colitis. 6:77-85. 2012
- Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses.. CADTH technology overviews. 2:e2101. 2012
- Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e166-e178. 2012
- Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. ClinicoEconomics and Outcomes Research. 4:287-287. 2012
- Cost-effectiveness of interventions for chronic obstructive pulmonary disease (COPD) using an Ontario policy model.. Ontario Health Technology Assessment Series. 12:1-61. 2012
- Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.. Ontario Health Technology Assessment Series. 12:1-41. 2012
- Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. ClinicoEconomics and Outcomes Research. 4:21-21. 2012
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B).. Ontario Health Technology Assessment Series. 12:1-62. 2012
- A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patients with diabetes mellitus: a study protocol. Trials. 12:69. 2011
- Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies - PREDICT - Rationale, Development and Implementation. BMC Emergency Medicine. 11:4. 2011
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskeletal Disorders. 12:209. 2011
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis. Seminars in Arthritis and Rheumatism. 41:178-186. 2011
- Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Review of Pharmacoeconomics and Outcomes Research. 11:513-521. 2011
- Using the Appropriate Fishing Net for Computed Tomographic Coronary Angiography in Daily Clinical Practice. JAMA Internal Medicine. 171:1512-1512. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources.. International Journal of Circumpolar Health. 70:417-427. 2011
- A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surgical Endoscopy. 25:2547-2554. 2011
- Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community. Diabetes Reviews. 34:1794-1798. 2011
- Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Quality of Life Research. 20:939-943. 2011
- Ontario Multidetector Computed Tomographic Coronary Angiography Study. JAMA Internal Medicine. 171:1021-1029. 2011
- A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community. American Society of Nephrology. Clinical Journal. 6:1241-1247. 2011
- Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease. American Society of Nephrology. Clinical Journal. 6:1248-1257. 2011
- Economic Evaluation of Reamed versus Unreamed Intramedullary Nailing in Patients with Closed and Open Tibial Fractures: Results from the Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures (SPRINT). Value in Health. 14:450-457. 2011
- Triple Therapy for the Management of COPD: A Review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 8:206-243. 2011
- A Splint Was Not Inferior to a Cast for Distal Radial Fracture in Children. Journal of Bone and Joint Surgery. American volume. 93:970-970. 2011
- Cost-effectiveness analysis of cast versus splint in children with acceptably angulated wrist fractures. International Journal of Technology Assessment in Health Care. 27:101-107. 2011
- Coverage with evidence development: The Ontario experience. International Journal of Technology Assessment in Health Care. 27:159-168. 2011
- Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation. Value in Health. 14:263-273. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources. International Journal of Circumpolar Health. 70:419-427. 2011
- Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). The BMJ. 342:d442-d442. 2011
- Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).. The BMJ. 342:d442. 2011
- New glaucoma diagnostic technologies: a systematic review of economic studies. Canadian Journal of Ophthalmology. 46:89-91. 2011
- Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances: A Simulation Study to Assess Model Performance. PLoS ONE. 6:e25635-e25635. 2011
- Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada. International Journal of Vascular Medicine. 2011:1-10. 2011
- Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. ClinicoEconomics and Outcomes Research. 3:89-89. 2011
- Community based intervention to optimize osteoporosis management: randomized controlled trial. BMC Geriatrics. 10:60. 2010
- The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions. PharmacoEconomics (Auckland). 28:1079-1096. 2010
- The importance of adjusting for potential confounders in Bayesian hierarchical models synthesising evidence from randomised and non-randomised studies: an application comparing treatments for abdominal aortic aneurysms. BMC Medical Research Methodology. 10:64. 2010
- Cast versus splint in children with minimally angulated fractures of the distal radius: a randomized controlled trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1507-1512. 2010
- General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals. Expert Review of Pharmacoeconomics and Outcomes Research. 10:379-384. 2010
- Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?. Value in Health. 13:487-494. 2010
- Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario. Value in Health. 13:S8-S11. 2010
- Reply by the Authors. Urology. 75:1236-1237. 2010
- Systematic Review and Meta-analysis of Transurethral Resection of the Prostate Versus Minimally Invasive Procedures for the Treatment of Benign Prostatic Obstruction. Urology. 75:1015-1022. 2010
- A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment. PharmacoEconomics (Auckland). 28:255-277. 2010
- Estimating the National Wage Loss from Cancer in Canada. Current Oncology. 17:40-49. 2010
- Patient outcomes after anti TNF-α drugs for Crohn’s disease. Expert Review of Pharmacoeconomics and Outcomes Research. 10:163-175. 2010
- Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature. Value in Health. 13:328-334. 2010
- Medication recommendations to physicians by pharmacists for seniors: expected clinical impact in relation to implementation and expected time frame to effect. International Journal of Pharmacy Practice. 16:159-165. 2010
- Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. European Journal of Health Economics. 11:27-34. 2010
- Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.. Open Medicine. 4:e154-e166. 2010
- A review of health utilities across conditions common in paediatric and adult populations. Health and Quality of Life Outcomes. 8:12-12. 2010
- Capacity Constraints and Cost-Effectiveness: A Discrete Event Simulation for Drug-Eluting Stents. Medical decision making. 30:16-28. 2010
- Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation. 8:14-14. 2010
- Evaluation of health outcomes in osteoarthritis patients after total knee replacement: a two-year follow-up. Health and Quality of Life Outcomes. 8:87-87. 2010
- Community-based intervention to optimise falls risk management: a randomised controlled trial. Age and Ageing. 38:724-730. 2009
- Handling uncertainty in economic evaluations of patient level data: A review of the use of Bayesian methods to inform health technology assessments. International Journal of Technology Assessment in Health Care. 25:546-554. 2009
- Cost Analysis of Multiplex PCR Testing for Diagnosing Respiratory Virus Infections. Journal of Clinical Microbiology. 47:2812-2817. 2009
- A review of the cost of cardiovascular disease. Canadian Journal of Cardiology. 25:e195-e202. 2009
- Approaches for Economic Evaluations of Health Care Technologies. Journal of the American College of Radiology. 6:307-316. 2009
- Conditionally Funded Field Evaluations and Practical Trial Design Within a Health Technology Assessment Framework. Journal of the American College of Radiology. 6:324-331. 2009
- Health Technology Assessment From a Canadian Device Industry Perspective. Journal of the American College of Radiology. 6:353-359. 2009
- Health Technology Assessment and Primary Data Collection for Reducing Uncertainty in Decision Making. Journal of the American College of Radiology. 6:332-342. 2009
- Health Technology Assessment for Radiologists: Basic Principles and Evaluation Framework. Journal of the American College of Radiology. 6:299-306. 2009
- Health Technology Assessment: A Review of International Activity and Examples of Approaches With Computed Tomographic Colonography. Journal of the American College of Radiology. 6:343-352. 2009
- Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada. Journal of the American College of Radiology. 6:317-323. 2009
- Introduction: Health Technology Assessment in Diagnostic Imaging. Journal of the American College of Radiology. 6:297-298. 2009
- Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. Clinical Therapeutics. 31:1082-1091. 2009
- Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications. Journal of the American College of Cardiology. 53:1773-1782. 2009
- Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario. International Journal of Technology Assessment in Health Care. 25:196-207. 2009
- In search of the evidentiary foundation of published Canadian economic evaluations (2001–06). International Journal of Technology Assessment in Health Care. 25:214-221. 2009
- A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada. Value in Health. 12:245-252. 2009
- Paclitaxel Versus Sirolimus Stents in Diabetic and Nondiabetic Patients. Circulation. Cardiovascular Quality and Outcomes. 2:96-107. 2009
- Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis. Cost Effectiveness and Resource Allocation. 7:20-20. 2009
- Excess Risk of Mortality and Complications Associated with Newly Diagnosed Cases of Diabetes in Ontario, Canada. Canadian Journal of Diabetes. 33:93-104. 2009
- Prevalence, Total and Excess Costs of Diabetes and Related Complications in Ontario, Canada. Canadian Journal of Diabetes. 33:35-45. 2009
- Reply. Journal of Vascular Surgery. 49:277-278. 2009
- The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.. Journal of Population Therapeutics and Clinical Pharmacology. 16:e346-e359. 2009
- Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies. Trials. 9:62. 2008
- Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial). European Journal of Pain. 12:1047-1058. 2008
- Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. Journal of Vascular Surgery. 48:779-787. 2008
- Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?. International Journal of Technology Assessment in Health Care. 24:437-444. 2008
- Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients. Circulation. Cardiovascular Quality and Outcomes. 1:12-20. 2008
- Effect of PCI on Quality of Life in Patients with Stable Coronary Disease. New England Journal of Medicine. 359:677-687. 2008
- Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis. Journal of Studies on Alcohol and Drugs. 69:510-519. 2008
- Cardiovascular Health Awareness Program (CHAP): A community cluster-randomised trial among elderly Canadians. Preventive Medicine. 46:537-544. 2008
- Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Quality of Life Research. 17:595-601. 2008
- Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Canadian Journal of Ophthalmology. 43:213-217. 2008
- Patient Views on Reminder Letters for Influenza Vaccinations in an Older Primary Care Patient Population. Canadian Journal of Public Health. 99:133-136. 2008
- Basics of Health Technology Assessment. Methods in molecular biology (Clifton, N.J.). 473:263-283. 2008
- Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. International Journal of Technology Assessment in Health Care. 24:87-95. 2008
- Effects of study design and trends for EVAR versus OSR. Vascular Health and Risk Management. Volume 4:1011-1022. 2008
- Money matters: what to look for in an economic analysis. Acta Orthopaedica. 79:1-11. 2008
- Practice and Physician Characteristics Associated with Influenza Vaccination Delivery Rates Following a Patient Reminder Letter Intervention. JOURNAL OF PREVENTION. 29:93-97. 2008
- Effectiveness and Safety of Drug-Eluting Stents in Ontario. New England Journal of Medicine. 357:1393-1402. 2007
- Costs of New Atypical Antipsychotic Agents for Schizophrenia: Does Unrestricted Access Reduce Hospital Utilization?. Healthcare Policy. 3:58-79. 2007
- Establishing a comprehensive continuum from an evidentiary base to policy development for health technologies: The Ontario experience. International Journal of Technology Assessment in Health Care. 23:299-309. 2007
- The cost of laparoscopic myotomy versus pneumatic dilatation for esophageal achalasia. Surgical Endoscopy. 21:1198-1206. 2007
- The Use of Hip Protectors in Long-Term Care Facilities: A Survey of Nursing Home Staff. Journal of the American Medical Directors Association. 8:229-232. 2007
- Optimal Medical Therapy with or without PCI for Stable Coronary Disease. New England Journal of Medicine. 356:1503-1516. 2007
- The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty. Journal of Bone and Joint Surgery. American volume. 89:819-828. 2007
- Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion. 23:671-682. 2007
- A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.. Journal of Population Therapeutics and Clinical Pharmacology. 14:e215-e226. 2007
- A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.. Journal of Population Therapeutics and Clinical Pharmacology. 14:e215-e226. 2007
- Being Led Down the Wrong Garden PATH: the Importance of Knowledge and Facts for the Crossroads. PharmacoEconomics (Auckland). 25:528-532. 2007
- Costs Associated with Erythropoiesis-Stimulating Agent Administration to Hemodialysis Patients. Nephron. 106:c193-c198. 2007
- Long-Term Cost-utility Analysis of a Multidisciplinary Primary Care Diabetes Management Program in Ontario. Canadian Journal of Diabetes. 31:205-214. 2007
- Photodynamic Therapy for Barrett’s Esophagus with High-Grade Dysplasia: A Cost-Effectiveness Analysis. Canadian Journal of Gastroenterology and Hepatology. 21:217-222. 2007
- Primary data collection in health technology assessment. International Journal of Technology Assessment in Health Care. 23:24-29. 2007
- A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastroesophageal Reflux Disease: One-Year Follow-Up. Surgical Innovation. 13:238-249. 2006
- A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics. Journal of Evaluation in Clinical Practice. 12:463-470. 2006
- Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. Current Medical Research and Opinion. 22:1425-1436. 2006
- Effect of a Clinical Pathway to Reduce Hospitalizations in Nursing Home Residents With Pneumonia. Journal of the American Medical Association (JAMA). 295:2503-2503. 2006
- Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. American Heart Journal. 151:1180-1185. 2006
- A Randomized Clinical Trial of Lung Volume Reduction Surgery Versus Best Medical Care for Patients With Advanced Emphysema: A Two-Year Study From Canada. Annals of Thoracic Surgery. 81:314-321. 2006
- Building Bridges Between Academic Research and Policy Formulation. PharmacoEconomics (Auckland). 24:1143-1156. 2006
- Economic Evaluation of Rivastigmine in Patients with Parkinson??s Disease Dementia. PharmacoEconomics (Auckland). 24:93-106. 2006
- The economic burden of schizophrenia in Canada in 2004. Current Medical Research and Opinion. 21:2017-2028. 2005
- A Randomized Trial of Strategies for Assessing Eligibility for Long-Term Domiciliary Oxygen Therapy. American Journal of Respiratory and Critical Care Medicine. 172:573-580. 2005
- A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. American Journal of Respiratory and Critical Care Medicine. 172:573-580. 2005
- Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.. Canadian Journal of Cardiology. 21 Suppl A:11A-18A. 2005
- Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis. Health Economics. 14:327-338. 2005
- Cost-effectiveness of physiologic pacing: Results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm. 2:270-275. 2005
- Antiviral Agents for Influenza. PharmacoEconomics (Auckland). 23:1083-1106. 2005
- Cost of stroke in Canada: a 1-year prospective study. Journal of Medical Economics. 8:147-167. 2005
- Unfinished Symphony: A Tribute to the Life and Career of Bernie O’Brien (1959–2004). Medical decision making. 24:538-544. 2004
- Principles of good modeling practice in healthcare cost-effectiveness studies. Expert Review of Pharmacoeconomics and Outcomes Research. 4:189-198. 2004
- Cost-effectiveness modeling in rheumatology: toward principles of good practice.. The Journal of rheumatology. Supplement. 68:21-22. 2003
- Methods for Patient-Level Costing in the VA System: Are they Applicable to Canada?. Medical Care Research and Review. 60:142S-145S. 2003
- Methods for patient-level costing in the VA system: Are they applicable to Canada?. Medical Care Research and Review. 60:142S-145S. 2003
- Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada. Value in Health. 6:116-125. 2003
- Validation of the GSFQ, a Self-Administered Symptom Frequency Questionnaire for Patients with Gastroesophageal Reflux Disease. Canadian Journal of Gastroenterology and Hepatology. 17:307-312. 2003
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease. Medical decision making. 22:290-308. 2002
- Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn. Value in Health. 5:312-328. 2002
- Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease. Medical decision making. 22:290-308. 2002
- Age, health and the willingness to pay for mortality risk reductions: A contingent valuation survey of Ontario residents. Journal of Risk and Uncertainty. 24:161-186. 2002
- Cost-Effectiveness of Screening Swab or Urine Specimens for Chlamydia trachomatis From Young Canadian Women in Ontario. Sexually Transmitted Diseases. 28:701-709. 2001
- Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective. Clinical Therapeutics. 23:2038-2049. 2001
- Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator. Circulation. 104:1622-1626. 2001
- Economic Implications of Hip Fracture: Health Service Use, Institutional Care and Cost in Canada. Osteoporosis International. 12:271-278. 2001
- Cost-Effectiveness of the Implantable Cardioverter-Defibrillator. Circulation. 103:1416-1421. 2001
- Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. Annals of Thoracic Surgery. 71:425-433. 2001
- Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC??)* for Helicobacter pylori Eradication. PharmacoEconomics (Auckland). 19:831-843. 2001
- Systematic Implementation of an Advance Directive Program in Nursing Homes. Journal of the American Medical Association (JAMA). 283:1437-1437. 2000
- Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?. American Heart Journal. 139:423-429. 2000
- Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis. JAMA Internal Medicine. 159:2298-2304. 1999
- The Economic Burden of Schizophrenia in Canada. Canadian Journal of Psychiatry. 44:464-472. 1999
- The Valuation of Productivity Costs Due to Premature Mortality: A Comparison of the Human-Capital and Friction-Cost Methods for Schizophrenia. Canadian Journal of Psychiatry. 44:455-463. 1999
- Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada. Journal of The American Geriatrics Society. 47:570-578. 1999
- Economic Evaluation of Long Term Management Strategies for Erosive Oesophagitis. PharmacoEconomics (Auckland). 16:679-697. 1999
- Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations. PharmacoEconomics (Auckland). 15:561-572. 1999
- Economic Evaluation of Hybrid Capture Human Papillomavirus Testing in Women with Low-Grade Papanicolaou Smear Abnormalities. Journal of Lower Genital Tract Disease. 2:213-220. 1998
- Relation between severity of Alzheimer's disease and costs of caring.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 159:457-465. 1998
- Assessing the Value of a New Pharmaceutical. Medical Care. 36:370-384. 1998
- A Canadian Physician Survey of Dyspepsia Management. Canadian Journal of Gastroenterology and Hepatology. 12:83-90. 1998
- Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:1519-1525. 1997
- Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. TERMPROM Study Group. Term Prelabour Rupture of the Membranes.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:1519-1525. 1997
- Health economics of gastroesophageal reflux disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:108B-112B. 1997
- The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.. Canadian Journal of Gastroenterology and Hepatology. 11 Suppl B:7B-20B. 1997
- Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children.. AIDS Patient Care and STDs. 8:4-11. 1997
- Cost effectiveness of Alternative Helicobacter pylori Eradication Strategies in the Management of Duodenal Ulcer. Canadian Journal of Gastroenterology and Hepatology. 11:323-331. 1997
- A Controlled Trial of Nurse Practitioners in Neonatal Intensive Care. Pediatrics. 98:1143-1148. 1996
- A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics. 98:1143-1148. 1996
- Switching the Histamine H2 Receptor Antagonist Famotidine to Nonprescription Status in Canada. PharmacoEconomics (Auckland). 9:61-75. 1996
- Cost analysis of dialysis treatments for end-stage renal disease (ESRD).. Clinical and Investigative Medicine. 18:455-464. 1995
- Investigation for mediastinal disease in patients with apparently operable lung cancer. Annals of Thoracic Surgery. 60:1382-1389. 1995
- Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. JAMA Internal Medicine. 155:1958-1964. 1995
- Cost-effectiveness of induction of labour versus serial antenatal monitoring in the Canadian Multicentre Postterm Pregnancy Trial.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:1445-1450. 1995
- Interprovincial Comparisons of Public and Private Sector Long-Term Care Facilities for the Elderly in Canada. Canadian Public Policy/ Analyse de Politiques. 20:278-278. 1994
- Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 150:1083-1090. 1994
- Prevalence of Migraine Headache in Canada: A Population-Based Survey. International Journal of Epidemiology. 23:1020-1026. 1994
- In vitro fertilization and embryo transfer: a randomized controlled trial.. The Online journal of current clinical trials. Doc No 73:[3483-words. 1993
- The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Social Science and Medicine. 34:983-991. 1992
- The cost-effectiveness of routine post myocardial infarction exercise stress testing.. Canadian Journal of Cardiology. 6:157-163. 1990